Cardinal Health, Inc. (NYSE:CAH) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Cardinal Health, Inc. (NYSE:CAH) have been given an average recommendation of “Moderate Buy” by the fourteen research firms that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $206.4615.

CAH has been the subject of a number of recent analyst reports. TD Cowen upped their price target on shares of Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. UBS Group boosted their price objective on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Finally, Leerink Partners increased their target price on Cardinal Health from $211.00 to $230.00 and gave the stock an “outperform” rating in a research report on Monday.

Insider Activity at Cardinal Health

In related news, CEO Jason M. Hollar sold 35,901 shares of the company’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the completion of the transaction, the chief executive officer owned 200,000 shares in the company, valued at approximately $30,008,000. This represents a 15.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.12% of the company’s stock.

Institutional Trading of Cardinal Health

Several hedge funds have recently bought and sold shares of the stock. Wellington Management Group LLP lifted its position in Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares during the last quarter. Norges Bank purchased a new stake in shares of Cardinal Health during the 2nd quarter valued at about $584,420,000. JPMorgan Chase & Co. lifted its holdings in shares of Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. Holocene Advisors LP grew its position in Cardinal Health by 141.4% in the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after acquiring an additional 1,128,358 shares in the last quarter. Finally, Zurich Insurance Group Ltd FI increased its stake in Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after acquiring an additional 927,950 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.4%

Shares of CAH opened at $206.25 on Tuesday. The business has a 50-day simple moving average of $166.70 and a two-hundred day simple moving average of $159.64. Cardinal Health has a 52 week low of $114.60 and a 52 week high of $208.32. The stock has a market cap of $49.00 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm’s revenue was up 22.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities analysts anticipate that Cardinal Health will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.